Notes
HBV = hepatitis B virus
Reference
Medicines and Healthcare products Regulatory Agency (UK). Ibrutinib (Imbruvica): reports of ventricular tachyarrhythmia; risk of hepatitis B reactivation and of opportunistic infections. Drug Safety Update 11: 2-3, No. 1, Aug 2017. Available from: URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/637656/DSU-August_PDF.pdf
Rights and permissions
About this article
Cite this article
Ibrutinib: ADRs that warrant temporary discontinuation. Reactions Weekly 1667, 2 (2017). https://doi.org/10.1007/s40278-017-35134-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-35134-5